Showing results (841-850 of 1,191) with videos related to

Sort By:
Pageof 120
BMC Pharmacology & Toxicology|August 5, 2024
Pharmacokinetic/Pharmacodynamic modelling of Saxagliptin and its active metabolite, 5-hydroxy Saxagliptin in rats with Type 2 Diabetes MellitusTianyan Wang, Ting Tao, Yi Liu, et al.
BMC Pharmacology & Toxicology|May 15, 2025
A study on the pharmacokinetic bioequivalence of oral tablet formulations of riluzole among healthy volunteers utilizing HPLC-MS/MSFei Yu, Rui Wang, Keli Wang, et al.
BMC Pharmacology & Toxicology|May 6, 2025
Adverse drug events observed with intrathecal magnesium sulfate as an adjuvant to bupivacaine for spinal anesthesia in patients undergoing elective cesarean section: a meta-analysisYuanhui Zhang, Yan Huang, Jun Li
BMC Pharmacology & Toxicology|April 29, 2025
Optimization and preparation of in-situ mucoadhesive gel of azithromycin hydroxypropyl-β-cyclodextrin inclusion complex against upper respiratory tract infectionsJitu Halder, Shuvam Mishra, Ivy Saha, et al.
BMC Pharmacology & Toxicology|April 9, 2025
Comparison of the efficacy of sucroferric oxyhydroxide and lanthanum carbonate in the hyperphosphatemia of maintainable HemodialysisMin Li, YiJing Kang, Chao Zhang, et al.
BMC Pharmacology & Toxicology|March 28, 2025
Protective effects of lipid emulsion on vital organs through the LPS/TLR4 pathway in acute organophosphate poisoningGang Li, Haiyan Hu
BMC Pharmacology & Toxicology|April 1, 2025
Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)Yaxin Qu, Shuxin Wang, Hanzhang Xie, et al.
BMC Pharmacology & Toxicology|April 23, 2025
Integrative analysis reveals key molecular mechanisms and prognostic model for Ethylnitrosourea-induced gliomagenesisBo Tan, Tao Chen, Peng Song, et al.
BMC Pharmacology & Toxicology|April 8, 2025
Development and validation of simple colorimetric methods for assessing norfloxacin in pure form, in pharmaceutical products and in biological materialMuhammad Naeem Khan, Muhammad Adnan, Nusrat Bibi, et al.
BMC Pharmacology & Toxicology|March 15, 2025
Adverse event profile of crizotinib in real-world from the FAERS database: a 12-year pharmacovigilance studyHuan Zhang, Yunrui Song, Fantong Xia, et al.
Pageof 120